
BlueRock Therapeutics is a clinical-stage cell therapy company focused on developing cellular medicines for neurological and ophthalmic diseases. It has two clinical-stage programs—one for Parkinson’s disease and another for primary photoreceptor disorders—illustrating its commitment to tackling devastating conditions. Founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer, BlueRock became a wholly owned subsidiary of Bayer AG in 2019, providing strong financial and scientific backing. The company distinguishes itself through a culture of perseverance, urgency to transform medicine, and integrity, driving innovation that aims to deliver hope to patients worldwide.
BlueRock Therapeutics is a clinical stage cell therapy company seeking an Intern, Financial Planning & Analytics to support financial planning, forecasting, and analytic activities. The successful candidate will gain exposure to financial modeling, business performance analysis, and the broader strategic priorities of the Finance organization.
BlueRock Therapeutics is a clinical-stage cell therapy company focused on developing cellular medicines for neurological and ophthalmic diseases. It has two clinical-stage programs—one for Parkinson’s disease and another for primary photoreceptor disorders—illustrating its commitment to tackling devastating conditions. Founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer, BlueRock became a wholly owned subsidiary of Bayer AG in 2019, providing strong financial and scientific backing. The company distinguishes itself through a culture of perseverance, urgency to transform medicine, and integrity, driving innovation that aims to deliver hope to patients worldwide.